Search results for "molecular microbiology"

Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control

PSL’s Clara™ 6 Well plate system is uniquely designed to provide the missing piece in mid-scale in vitro production and filtration, including isolation of biological material such as proteins and plasmid DNA from up to 50 mL of culture

Ideal for scientists who need to easily and quickly transfer liquid aliquots from one container to another with precision.

Independent of your genes of interest, our easy RNA in situ hybridization assay uses common reagents and protocols; providing universal assay conditions. All RNA-ISH kits contain reagents in a convenient ready-to-use (RTU) format, and chromogenic dyes are available to interrogate a single or two genes simultaneously.

Small working volumes save valuable material and medium in process development and screening procedures. The Eppendorf DASbox Mini Bioreactor is a fully instrumented mini bioreactor featuring industry standard design and advanced control functionalities.

Alfa Chemistry highlights a key challenge in natural-product drug discovery: ensuring reliable access to well-characterized compounds, enabling SAR studies, biological validation, and progression of promising leads

High throughput label-free performance.

SelectScience clinical CPD webinars can be added to HCPC and IBMS portfolios as evidence of CPD

Eppendorf Tubes ® BioBased are a new era of laboratory tubes made with bio-based, eco-friendly polymer that doesn’t sacrifice quality or performance.

RNase Block Ribonuclease Inhibitor is a 50-kDa protein that specifically inhibits common eukaryotic RNases including RNase A, RNase B, and RNase C. 

Specially treated Human Serum Albumin, optimized for human ES and iPS cell culture. Designed for optimal cryopreservation of hMSCs

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions